|
Therapeutics and Targets
Contributing journals to this collection:
Cancer Prevention Journals Portal,
Cancer Prevention Journals Portal Content,
,
Cancer Reviews Online,
Molecular Cancer Research,
Cancer Prevention Research,
Molecular Cancer Therapeutics,
Cancer Research,
Cancer Reviews Online Content,
Clinical Cancer Research,
and Cancer Epidemiology Biomarkers & Prevention
Citations 21-30 of 167 total displayed.
- Reviews
MicroRNA Silencing in Primates: Towards Development of Novel Therapeutics
- Andreas Petri, Morten Lindow, and Sakari Kauppinen
Cancer Res. 2009; 69: 393-395.
[Abstract]
[Full text]
[PDF]
- Reviews
On the Role of Cell Signaling Models in Cancer Research
- Alejandra C. Ventura, Trachette L. Jackson, and Sofia D. Merajver
Cancer Res. 2009; 69: 400-402.
[Abstract]
[Full text]
[PDF]
- Subject Review
Targeting Mdm2 and Mdmx in Cancer Therapy: Better Living through Medicinal Chemistry?
- Mark Wade and Geoffrey M. Wahl
Mol. Cancer Res. 2009; 7: 1-11.
[Abstract]
[Full text]
[PDF]
- Reviews
Take your PIK: phosphatidylinositol 3-kinase inhibitors race through the clinic and toward cancer therapy
- Nathan T. Ihle and Garth Powis
Mol. Cancer Ther. 2009; 8: 1-9.
[Abstract]
[Full text]
[PDF]
- Reviews
Platinum neurotoxicity pharmacogenetics
- Sarah R. McWhinney, Richard M. Goldberg, and Howard L. McLeod
Mol. Cancer Ther. 2009; 8: 10-16.
[Abstract]
[Full text]
[PDF]
- Reviews
Ixabepilone: targeting βIII-tubulin expression in taxane-resistant malignancies
- Charles Dumontet, Mary Ann Jordan, and Francis F.Y. Lee
Mol. Cancer Ther. 2009; 8: 17-25.
[Abstract]
[Full text]
[PDF]
- CCR Focus
Triple-Negative Breast Cancer: Risk Factors to Potential Targets
- Bryan P. Schneider, Eric P. Winer, William D. Foulkes, Judy Garber, Charles M. Perou, Andrea Richardson, George W. Sledge, and Lisa A. Carey
Clin. Cancer Res. 2008; 14: 8010-8018.
[Abstract]
[Full text]
[PDF]
- Reviews
Drug Resistance Caused by Reversion Mutation
- Alan Ashworth
Cancer Res. 2008; 68: 10021-10023.
[Abstract]
[Full text]
[PDF]
- Minireviews
Challenge and promise: roles for Livin in progression and therapy of cancer
- Ling Wang, Qi Zhang, Bin Liu, Mei Han, and Baoen Shan
Mol. Cancer Ther. 2008; 7: 3661-3669.
[Abstract]
[Full text]
[PDF]
- Reviews
Novel therapeutic strategy for osteosarcoma targeting osteoclast differentiation, bone-resorbing activity, and apoptosis pathway
- Toru Akiyama, Crispin R. Dass, and Peter F.M. Choong
Mol. Cancer Ther. 2008; 7: 3461-3469.
[Abstract]
[Full text]
[PDF]
|
|
Collected Resources Home
|
|
|
|